Abstract: Genomic sequence comparisons between human, mouse and pufferfish (Takifugu rubripes (Fugu)) have revealed a set of extremely conserved noncoding sequences. While this high degree of sequence conservation suggests severe evolutionary constraint and predicts a lack of tolerance to change in order to retain in vivo functionality, such elements have been minimally explored experimentally. In this study, we describe the in-depth characterization of an ancient conserved enhancer, Dc2 located near the dachshund gene, which displays a human-Fugu identity of 84% over 424 basepairs (bp). In addition to this large overall conservation, we find that Dc2 is characterized by the presence of a large block of sequence (144 bp) that is completely identical between human, mouse, chicken, zebrafish and Fugu. Through the testing of reporter vector constructs in transgenic mice, we observed that the 424 bp Dc2 conserved element is necessary and sufficient for brain tissue enhancer activity. In vivo analyses also revealed that the 144 bp 100% conserved sequence is necessary, but not sufficient, to replicate Dc2 enhancer function. However, the introduction of two separate 16 bp insertions into the highly conserved enhancer core did not cause any detectable modification of its in vivo activity. Our observations indicate that the 144 bp 100% conserved element is tolerant of change at least at the resolution of this transgenic mouse assay and suggest that purifying selection on Dc2 sequence might not be as strong as we predicted or that some unknown property also constrains this highly conserved enhancer sequence. Thank you for your letter of February 15 th and for the reviewers' comments on our manuscript entitled "In Vivo Characterization of a Vertebrate Ultra-conserved Enhancer", by Poulin et al. We have addressed the reviewers' concerns in a revised manuscript, which we are resubmitting for your consideration.
Ph: 510-486-7498 Fax: 510-486-4229 Email: LAPennacchio@lbl.gov www.jgi.doe.gov if expression levels are affected).
We have modified the corresponding results section to specify that it is the expression pattern that is indistinguishable. In addition, we now mention in the discussion (p. 12) that our assay might not detect differences in expression levels.
7.
Results "The Highly Conserved Minimal Enhancer Core….". Authors state that linkers were designed not to introduce transcription factor binding sites. A TRANSFAC 8.1 search using a 6 bp seed revealed Sp1, retinoic acid receptor (alpha and beta), and AP-2 binding sites. Please provide the Genomatix parameters used and briefly discuss limitations in Discussion section.
The Genomatix parameters are now included in the Methods section (p. 13). In addition, we added a discussion of the limitations of our analysis for transcription factor binding sites presence (p. 11).
8.
Text, general. Consider downplaying the point that the enhancer is "tolerant to change". The authors actually argue (very well) in paragraph two of the discussion, why their approach may be insufficient to fully address this issue.
We have used the term "suggest" to qualify that they enhancer may not be tolerant to change. Ultimately an ultra-conserved knockout mouse will be required to address this issue and experiments are in progress towards this goal.
9.
Text, general. In the results and methods the authors state that they used a cut-off of more than 80 bp at least 70% identical for comparative sequence analyses. Please provide a brief rational for this in the discussion.
We have clarified this point in the Results section (p. 5). We selected Dc2 based on its extensive conservation over a region of 424bp, and the plots in Figure 2 more accurately illustrates the extent of the conservation in comparison with the surrounding sequence.
10.
Materials and Methods. General. More details should be provided, even though they may appear throughout the text. For instance: a. Provide primer sequences in first sentence of "cloning" for original enhancer amplification or refer to specific line in Table 1 .
We now refer to the primers sequence in Table 1 .
b. Provide bp positions and figure reference for linkers in "cloning".
We now include the actual position of the insertion in reference to Figure 2.
c.
As stated earlier, please provide parameters for Genomatix in "cloning".
We have made this change. We have made this change.
11. Figure 3 . Add " ' " to Dc2 after DACH2 on lines 3, 6, and 9. Figure may read nicer if consensus is placed on bottom.
We added the " ' " to Dc2 after DACH2, and we also removed the consensus line.
12. Figure 4 . "N/A" seems inappropriate in the right-most column. This implies that the data was not collected, instead of being negative. Please consider changing to "Not Detected", "No Expression", or some alternative abbreviation with an explanatory footnote.
We changed the abbreviation to ND for "Not Detected".
Reviewer #3
1. It would have been informative if the authors had predicted potential transcription factor binding sites in the 424 bp putative enhancer sequence, and examined the distribution of binding sites in relation to the highly conserved 144 bp element and the regions disrupted by 16-bp insertion.
We agree with the reviewer that such a figure would be informative, and we have added a new Figure 3 to the manuscript. This new figure presents the transcription factors binding sites that are conserved between human and fugu in the 424bp enhancer, as well as the position of the two insertions.
We thank the reviewers for their constructive and thoughtful criticisms. We feel that we have responded satisfactorily to their comments, and that the paper is now acceptable for publication in Genomics. We have modified the corresponding results section to specify that it is the expression pattern that is indistinguishable. In addition, we now mention in the discussion (p. 12) that our assay might not detect differences in expression levels.
7.
8.
9.
10.
We now refer to the primers sequence in Table 1 . 
c.
Reviewer #3
We thank the reviewers for their constructive and thoughtful criticisms. We feel that we have responded satisfactorily to their comments, and that the paper is now acceptable for publication in Genomics. To whom correspondence should be addressed:
Introduction
Vertebrate comparative genomics has proven to be an effective approach to uncover functional elements in the human genome. This has been accomplished through comparison of the human genome with the genomes of a wide-range of species from primates to fish [1] [2] [3] [4] . The underlying success of this strategy is based on comparing sufficiently divergent genomes to distinguish neutral versus functionally constrained sequence elements [5, 6] . At one extreme, comparison of the human genome to the genome of a teleost fish, Takifugu rubripes (Fugu), has identified a set of anciently conserved coding and noncoding sequences [7, 8] .
Humans and Fugu last shared a common ancestor approximately 400 million years ago [9] and while the Fugu genome is one of the smallest known in vertebrates (365 Mb), its gene repertoire is similar to that of humans [10] . These characteristics led to the original proposal to sequence the Fugu genome in order to assist with the annotation of human genes based on comparative genomics [10] . Furthermore, the availability of Fugu genomic sequence also revealed that human-Fugu conserved noncoding sequences can be used to delineate gene regulatory sequences [1, [11] [12] [13] [14] [15] .
Many of the ancient elements conserved between human and Fugu overlap with recently described ultra-conserved human/rodent DNA elements [16] . Through the use of human/mouse/rat whole-genome comparisons, ultra-conserved elements were defined as sequences that are at least 200 bp and are absolutely conserved in these three species [16] .
Intriguingly, the non-exonic ultra-and human-Fugu conserved elements do not show a random distribution in the human genome, but tend to cluster near genes encoding transcription factors that are involved in developmental processes [16, 17] .
One example of clustered human-Fugu conserved noncoding elements are those surrounding DACH, a homolog of the Drosophila dachshund gene [18] . In both vertebrates and invertebrates dachshund displays a complex temporal and spatial pattern of expression, and the gene product is critical in the development of the central nervous system, sensory organs, and limbs [19] [20] [21] [22] 23] .
In vivo analysis of nine DNA elements conserved from human to Fugu demonstrated that seven displayed enhancer activities recapitulating some aspects of DACH expression [15] . The most surprising characteristic of these enhancers is their extremely high degree of conservation between humans and fish. For instance Dc2, a conserved regulatory element of human DACH that is known to drive expression in hindbrain, forebrain and the retina, is 84% identical over 424 bp to its Fugu ortholog. As impressive is the high degree of conservation within sub-regions of this element, with portions displaying greater than 99% identity over 270 bp among human, mouse and rat and greater than 98% identity over 219 bp between human and Fugu. This is especially striking considering the known degeneracy of the sequences recognized by transcription factors [24] , and this observation of extreme conservation suggests that other limitations may prevent these enhancers from changing over evolutionary time. To better characterize the nature of the sequence constraints in highly conserved vertebrate enhancers, we manipulated a single known element, the human Dc2 enhancer, in vivo through a series of reporter constructs tested in transgenic mouse assays.
Results
In this study, we characterized a single human-Fugu enhancer of the DACH locus (Dc2) through
(1) comparative genomic analyses to define "phylogenetic footprints", (2) deletion constructs in transgenic mice to experimentally define the minimal sequence necessary and sufficient for in vivo activity, and (3) targeted mutagenesis to assess whether the enhancer is tolerant of insertional disruption events.
Comparative Genomics Delineates Conserved Modules
The Dc2 enhancer was previously identified by comparing the sequences of the orthologous human and Fugu DACH genes [15] . Briefly, a human DNA fragment of 2,086 bp encompassing the sequence conserved in Fugu was tested in transgenic mice and demonstrated to enhance the activity of a minimal heat shock promoter (HSP68) fused to β-galactosidase (LacZ) [25] . The Dc2 enhancer was found to drive the expression of LacZ in the hindbrain, forebrain and retina of the developing mouse embryo [15] . In order to better define the sequence elements required for the enhancer function of Dc2, we performed comparative analysis of the functional element in multiple vertebrate species (Fig. 1A) .
Comparison of the human, mouse and rat sequences revealed several discrete elements of conservation throughout the enhancer when using an 80bp and 70% identity cut-off, slightly less stringent than the classically defined 100bp and 70% identity previously used in the identification of functional mammalian regulatory elements [3] (Fig. 1A; 4 human-mouse elements).
Comparison of the human and chicken sequences shows a decrease in the number of conserved 6 elements, but extensive conservation is still readily observed ( Fig. 1A ; two human-chicken elements). This is in contrast to the alignment of the human sequence with that of the more distant vertebrates, which highlights a single region of 424 bp that is more than 84% conserved in all the species analyzed (Fig. 1A , Human Dc2 to frog, zebrafish or Fugu). This region is 96%
identical to the mouse Dc2, and displays 84% identity between the human and Fugu Dc2 (Fig.   1A ).
Closer inspection of the alignment of this 424 bp region reveals that the largest uninterrupted block of perfect identity between human-mouse is 195 bp and that between human-Fugu is 144 bp in length (Fig. 2 ). This block of perfect identity can be expanded to a remarkable 270 bp with a single mismatch between human and mouse Dc2 (Fig. 2 , human nucleotides 75 to 345).
Similarly, the human-Fugu conservation is 98% for a block of 219 bp from human nucleotides 90 to 308 (Fig. 2) . This large block is flanked by shorter regions where the similarity between species is lower (Fig. 2) , suggesting that the enhancer is composed of a core sequence that is highly constrained, and satellite sequences that can evolve more rapidly. Analysis of the 424 bp conserved region with rVista 2.0 [26] predicts 111 and 114 putative transcription factor binding sites in the human and Fugu sequence, respectively. Of these sites, 72 are conserved in both species (Fig. 3) , with 44 sites landing in the 144bp/100% conserved core (61%; Fig. 3 , green box).
Comparison of Dc2 to the human genome also uncovered a single additional region of sequence similarity (which we will refer to as Dc2') on chromosome X. Upon detailed further examination of the flanking sequence, we found that Dc2' lies within DACH2, a known paralog of DACH that arose from an ancient genomic duplication event predating the divergence of the mammalian and 7 fish lineages (Fig. 4) . Similar to Dc2, Dc2' is located in the first intron of DACH2, with both displaying similar enhancer properties in transgenic mice, further supporting their common origin (data not shown). Alignment of the human Dc2 to the paralogous Dc2' sequence from multiple vertebrates shows a more limited region of similarity between the two elements (Fig. 1B) . The human Dc2' contains the most conserved portion of the DACH Dc2 enhancer ( Fig. 2; 144 bp, Human-Fugu Dc2 100% identity), but overall has a lower degree of sequence conservation ( Fig.   4 ; 144 bp, Human Dc2-Dc2' 86% identity).
Refinement of the Minimal Necessary Dc2 Enhancer
Using the results from our comparative analysis as a guide, we designed several Dc2 constructs to test for enhancer function in transgenic mouse embryos (Fig. 5) . As previously demonstrated [15] , we found that the wild-type construct displayed enhancer activity in all transgenic lines tested (Fig. 5B, WT) , with specific staining in the forebrain, hindbrain and retina (Fig. 5B, WT) .
To define the minimum fragment necessary for this activity, we tested a construct consisting of only the core 424 bp of sequence that are conserved in the DACH Dc2 orthologues from human to Fugu (Fig. 5B, 424 bp/84%). We found this 424 bp fragment consistently drove expression in transgenic embryos in a pattern indistinguishable from the parent 2,086 bp construct.
Conversely, we found that deletion of this 424 bp sequence from the parent (WT) construct completely abolished its activity in our transgenic assay (Fig. 5B, ∆424bp) . This finding suggests the small 424 bp element is able to carry out all the observed enhancer activities found in the full construct.
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To further explore the minimal sequence necessary for enhancer activity, we reduced the size of the conserved 424 bp fragment to the 144 bp Dc2 region 100% conserved between human and Fugu (Fig. 2, dashed line) , a segment that also shows similarity to the paralogous human Dc2' enhancer (Fig. 4) . We found that while this 144 bp sequence does not enhance transcription in transgenic mice (Fig. 5B, 144bp/100% ), its removal from the WT parental Dc2 construct completely abolished Dc2 enhancer activity (Fig. 5B, ∆144bp) . Taken together, these results demonstrate that, although human-mouse comparison shows several regions of sequence conservation (Fig. 1A) , the necessary and sufficient portion of the element is contained within the region shared between human and Fugu. Moreover, the region of the element that is shared between Dc2 and Dc2' is necessary, but not sufficient, for the function of the enhancer.
The Highly Conserved Minimal Enhancer Core is Tolerant of Insertion Mutations
Having defined the 144 bp core element as essential for enhancer function and 100% conserved between human and Fugu, we sought to determine its tolerance to sequence change. The large size of the minimal Dc2 enhancer and its extreme conservation raised several questions regarding the types of constraints acting on its sequence. To address whether the internal organization of the enhancer could limit its variation, we introduced DNA linkers into the phylogenetically conserved core of the enhancer (Fig. 2, arrows) . These linkers were 16 bp long, representing an approximately one and a half DNA helix turn, and were designed to not introduce new predicted transcription factor binding sites into the enhancer (see Methods). We chose the location of the insertions to disrupt the most constrained region of the enhancer (Fig. 2, arrows) , with one linker (insert 1) located in the segment that is absolutely conserved and has homology to DACH2 Dc2' 9 ( Fig. 2, dashed line) . Surprisingly, in studying the various transgenic lines containing these reporter constructs, we found that the two different linker insertions did not affect the WT reporter construct activity in the mouse embryos (Fig. 5B , Insert 1 and Insert 2), and the pattern of expression of these mutant constructs was not distinguishable from that of the WT construct.
Discussion
Comparative genomics is continuing to help localize conserved noncoding sequences with gene regulatory activity, and distant evolutionary comparisons between mammals and teleosts have proven especially efficient [1, 13, 15, 27] . In this study we characterized a gene enhancer (Dc2) identified through human-Fugu comparative genomics, and refined the sequences necessary and sufficient for its function, as well as assessed the impact of insertional mutations on its gene regulatory activity.
The Dc2 enhancer is characterized by the presence of a large block of sequence (144 bp) that is entirely identical between human and multiple distantly related species (mouse, rat, chicken, frog, zebrafish, and Fugu). This observation is similar to recent reports for mammalian ultraconserved sequences [16] , in spite of the fact that the Dc2 enhancer falls just short of the requirements of the ultra-conserved set (>200 bp, 100% identity). Nonetheless, a similarity in Another powerful aspect of vertebrate comparative genomics and gene regulatory sequence characterization is the occurrence of gene paralogs resulting from genomic duplications over the course of evolution. This is readily apparent with the human DACH gene and its Dc2 enhancer sharing similarity with the DACH2 paralog and the adjacent Dc2'. This duplication event is very ancient, predating the last common ancestor of human-Fugu, and both loci have strongly resisted sequence change in these functional sequences. Comparison between these paralogs revealed a small and highly conserved core (144 bp) that is necessary to preserve the enhancer function, but
is not sufficient to recapitulate it. This suggests that while it is critical to conserve the sequence of certain modules for the enhancer to function, some flanking sequences are more flexible to change. It is known that stabilizing selection can maintain an enhancer function in different species even when sequence conservation is limited because of turnover in transcription factor binding sites [28] . However, the fact that the flanking sequences are flexible in the Dc2 paralogs is contrasted by their extreme conservation in each of the individual orthologs. It therefore appears that the sequence of each of the paralogous elements changed rapidly after the duplication event, and that each eventually became fixed independently [16, 29] .
While enormous sequence conservation of human-Fugu and ultra-conserved elements alone predicts that any change in such an element would destroy its activity, our analyses indicate that the DACH Dc2 enhancer is much more flexible than anticipated. Two separate insertions in the highly conserved core of this enhancer did not cause any detectable modification in its activity in vivo. This could be due to the limitations of our assay, which occur at a single time point and
Materials and Methods

Cloning
Dc2 enhancer constructs were PCR amplified from human genomic DNA (BD Biosciences) and directionally cloned into the pENTR/D-TOPO vector (Invitrogen). The wild-type (WT), 424, and 144 Dc2 constructs were PCR amplified with the corresponding Forward and
Reverse primers described in Table 1 . Constructs containing site-specific mutations were generated by overlap extension PCR [30] , in which the mutagenic primers were used in combination with WT primers of opposite orientation (Table 1 ). All constructs were sequenced and transferred to the Gateway-HSP68-LacZ vector using the LR recombination reaction (Invitrogen). The elements were cloned in the same orientation relative to the Vertebrates matrices were used with the following parameters: core similarity: 0.75, matrix silmilarity: optimized.
Generation of transgenic mice
Plasmid DNA was purified using the EndoFree plasmid maxi kit (Qiagen). 100 µg of plasmid was linearized with XhoI, followed by purification on Micropure EZ columns and Montage PCR filter units (Millipore). The purified DNA was dialyzed for 24h against injection buffer (10 mM Tris, pH 7.5; 0.1 mM EDTA), and its concentration determined fluorometrically and by agarose gel electrophoresis. The DNA was diluted to a concentration of 1.5 to 2 ng/µl and used for pronuclear injections of FVB embryos [31] , in accordance with protocols approved by the Lawrence Berkeley National Laboratory.
Embryo staining
Embryos were harvested at 12.5 dpc and dissected in cold 100mM phosphate buffer pH 7. 
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